Delivery Order SPE2DB20D1100-SPE2DB24FB4W0
- Not listed
- This federal contract award, valued at $1,619.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,534,854 units of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, with a completion date of February 5, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $19,773.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,562,237,166 units of Rosuvastatin Calcium 40 mg tablets. The contract is a Firm Fixed Price Delivery Order that runs through September 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $157,458.83 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,669.34, is a delivery order for the supply of 1,000 tablets of Rosuvastatin Calcium 20 mg. The contract has an ultimate completion date of December 5, 2023 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $173,843.44 Firm Fixed Price Delivery Order covers the supply of 4,563,604,394 units of Rosuvastatin Calcium 40 mg Tablets in 500-count packages. The award is not designated as a set-aside and was made through full and open competition. It is associated with a larger Indefinite Delivery Contract (IDC) between the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $54,303.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The contract has an ultimate completion date of January 31, 2024 and is a firm fixed-price delivery order. No set-aside designation was used, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,563,448,409 Rosuvastatin Calcium 10 mg tablets in 1,000-count bottles. The $4,138.94 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,020.10 delivery order is for Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication. This award falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,811.90 Firm Fixed Price Delivery Order is for the provision of 4,565,048,564 units of Rosuvastatin Calcium 10 mg tablets. The contract has an ultimate completion date of July 2, 2024 and was awarded on July 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB4W0Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $26,023.34 firm fixed-price delivery order contract is for the supply of 4,564,414,347 units of Rosuvastatin Calcium 20 mg tablets. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 4/26/24 |